Interleukin-4 receptor (IL-4R): A drug target with massive potential

The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an attractive drug target and what this could entail.

Related Keywords

Alex Smith ,Keymed Biosciences ,Sanofi Regeneron ,Atridia Pty Ltd ,Syneos Health ,Pieris Australia Pty Ltd ,Astrazeneca ,Akeso Pharmaceuticals ,Jiangsu Hengrui Pharmaceuticals ,Sponsored Content ,Atopic Dermatitis ,Nasal Polyps ,Nasal Disorders ,Pty Ltd ,Novamab Biopharmaceuticals ,Image Credit ,His Tag ,Avi Tag ,Respiratory Review ,Treat Type ,Pediatr Drugs ,Content Policy ,News Medical Net ,Il 4r ,Nterleukin 4 Receptor ,Drug Target ,